Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thiamine for Left Ventricular Structure and Function After Transcatheter Closure in Children With Left-to-Right Shunt CHD
NCT06298344Phase 1Completed
- Sponsor
- Universitas Sumatera Utara
- Start
- May 2024
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial in congenital heart disease (CHD) comparing Thiamine with Placebo (2 arms). Primary endpoint: Correlation between transcatheter closure and left ventricular structure change after thiamine treatment at 28 days. Started May 2024; status: completed.
02
Drugs
thiamine
03
Conditions
congenital heart disease (CHD)
Beyond the preview
Go deeper on NCT06298344.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06298344.